acute-phase reaction proteins, which are calculated as part of the serum globulin, and suppress the synthesis of albumin (6) . In addition, albumin plays a significant role in the distribution and pharmacological activities of anticancer drugs (7) . As a consequence, low serum albumin and high serum globulin are two independent prognostic factors, as recently shown in various cancers (4, 5, 8) . Therefore, we suppose that albumin to globulin ratio (AGR) is a potential preoperative biomarker for the assessment of the clinicopathological features and prognosis.
To the best of our knowledge, several previous studies have demonstrated the correlation between the preoperative AGR and long-term survival of cancers (9) (10) (11) (12) (13) (14) , but GC has not been discussed. The purpose of this study was to find the cutoff value of AGR and to evaluate whether preoperative AGR has a prognostic value in patients with resectable GC.
MATERIALS AND METHODS

Patients
Ethics approval of our study was provided by the institutional review board of our hospital. We retrospectively reviewed patients who were diagnosed with GC and received gastrectomy with D2 lymphadenectomy and R0 resection from 2007 to 2012 at the Gastrointestinal Surgery Department. The inclusion criteria are as follows: pathological diagnosis is primary GC and absence of distant metastasis; no neoadjuvant chemotherapy; normal hepatic and renal function; and no history of chronic inflammatory disease or immunosuppressive therapy (1-4.) . However, patients with a history of coronary heart disease, hypertension, chronic lung disease, cerebrovascular disease, and type II diabetes mellitus could be enrolled in the study. A total of 269 patients met the inclusion criteria and all these patients signed informed consent approved by the institutional review board.
Clinical and Laboratory Data
All the clinical and laboratory data were collected from the hospital database. Specific information includes gender, age, comorbidities, preoperative laboratory variables, and tumor characteristics. Data of cases that underwent the postoperative chemotherapy were also collected, and the postoperative chemotherapy protocol was designed after operations according to the tumor stage and individual characteristics. The stage of GC was in accordance with the American Joint Committee on Cancer classification system (seventh edition, 2010), and the preoperative laboratory variables analyzed in this study were measured before any treatment. All the patients were followed up periodically after the surgery until death or June 2015. The last date or deadline of follow-up was applied for the censored cases.
The value of AGR was calculated with the formula [AGR=serum albumin/serum globulin], and the appropriate cutoff point of preoperative AGR was obtained using a receiver-operating characteristic curve ( Figure 1) . As a result, the area under the curve was 0.657, and 1.36 was selected as the cutoff value, whereas sensitivity and specificity were 0.709 and 0.554, respectively. Thus, the patients were classified into a low (<1.36) or high (≥1.36) AGR group. Using the same method, the value of 108 g/L was selected as the optimal cutoff value of preoperative hemoglobin.
Statistical Analysis
All statistical analyses were performed using Statistical Package for Social Sciences version 22.0 (IBM Corp.; Armonk, NY, USA). A chi-square or Fisher's exact test was used to evaluate the categorical variables, while an independent t-test was used for continuous variables between the high and low AGR groups. Moreover, binary logistic regression analysis was performed to identify any clinicopathological correlations with the low preoperative AGR value. The analysis of OS was performed using the Kaplan-Meier method and then compared using log-rank test. Univariate analyses were performed for all the variables, and those variables that were confirmed to be statistically significant were further analyzed by a multivariate Cox regression model. A p<0.05 is considered statistically significant in the analyses.
RESULTS
Preoperative AGR and Clinicopathological Characteristics
Statistical analysis divided 269 eligible GC patients into two groups by the cutoff point of preoperative AGR; 114 pa- The outcome of binary logistic regression analysis in Table 2 showed that four covariates were found to be independent risk factors of low preoperative AGR value; these include female gender, older age, larger tumor size, and lower preoperative hemoglobin level. 
Preoperative AGR and Prognosis of GC Patients
The median follow-up time was 40 months (range, 1-108 months). There were 130 surviving patients on the deadline of follow-up and 139 cases were confirmed to have died. In particular, 24 patients who were lost to follow-up were excluded in our study. The median OS of the low and high AGR groups was 13 months (95% CI, 10.9-15.1) and 17 months (95% CI, 13.8-20.2), respectively, (p=0.014). The Kaplan-Meier curve showed a significantly lower OS in the low AGR group compared to the high AGR group (Figure 2) . The univariate analysis of all the variables showed that age, tumor size, differentiation degree, T stage, N stage, TNM stage, preoperative AGR, and hemoglobin have significant influences on the prognosis of GC patients ( Table 3 ). The statistically significant parameters in univariate analysis were then enrolled in a multivariate analysis. Eventually, older age (≥70), worse N stage, and low preoperative AGR (<1.36) were confirmed the independent risk factors for the lower OS time of GC patients (Table 3) .
DISCUSSION
Our major finding is that preoperative AGR is significantly associated with the OS of GC patients. Preoperative AGR has been demonstrated as a prognostic predictor in various cancers (9-14), but there was no literature discussing the predictive value of preoperative AGR in GC patients when we were accomplishing this study. Interestingly, a similar research was recently published whose results indicated that AGR was just an independent disease-free survival marker and not the OS marker (15) . However, as the results showed, low preoperative AGR (<1.36) remained an independent prognostic factor for OS after controlling the irrelevant variables in a multivariable analysis. Therefore, more studies are needed to discuss the predictive value of preoperative AGR on the prognosis of GC patients.
The value of AGR is calculated with albumin and globulin, which are not only the two main constituents of serum protein that maintain osmotic pressure but also are affected by the nutritional status and systemic inflammation. There exists close interactions between serum albumin and tumors, with the results that the serum albumin level provides potential prognostic significance in cancer (5). Firstly, because of anepithymia and malabsorption, patients with gastrointestinal cancers have a higher risk of hypoalbuminemia compared to others (16) . Secondly, the tumor can induce systemic inflammation, which in turn, may be a stimulus for tumor and immune cells to produce cytokines, such as interleukin (IL)-1β, IL-6, and tumor necrosis factor. These cytokines have an effect on suppressing the synthesis of albumin and increasing the permeability of capillaries, which can promote the loss of albumin (5). Thirdly, as the major target of oxidant stress, albumin has an antioxidant function and prevents damage in lipids, nucleic acids, and other proteins (17) . Therefore, serum albumin plays an important role in stabilizing DNA replication and inhibiting carcinogenesis (18) . Lastly, serum albumin, a multifunctional protein in plasma, can influence the therapeutic efficacy of anticancer treatment. Recent studies have demonstrated that albumin has a great impact on the distribution and pharmacological activities of anticancer drugs as a transporter in plasma (7). Gupta et al. (5) reviewed 53 reports on the relation between serum albumin level and prognosis of different cancers, including GC, most of which concluded that lower albumin levels predicted a poorer survival. Similarly, our additional analysis showed that preoperative albumin was a significant predictor and protective factor of OS (OR=0.9; 95% CI, 0.9-1.0; p<0.001).
In contrast, serum globulin, also known as nonalbumin proinflammatory protein, has complex components, including acute phase proteins, immunoglobulins, interleukins, and tumor markers (19) . Prior studies have reported that some of these inflammation markers play an important role in the carcinogenesis, progression, metastasis, and recurrence of tumors (20) . In the study by Chen et al. (8) , low pretreatment serum globulin predicts a better prognosis for GC patients. Moreover, increases of some nonalbumin proinflammatory proteins, such as C-reactive protein, alpha and gamma globulin, complement C3, and IgA were also shown to have a negative impact on the survival of various cancer patients (21) (22) (23) . However, the univariate analysis of our data showed that preoperative globulin was not significantly correlated with OS (OR=1.0; 95% CI, 1.0-1.1; p=0.123). We presumed that the reasons for the negative result are that the actual value of globulin can be altered by hemodilution or hemoconcentration, and redundant components of globulin may cause errors in the outcome. Above all, both preoperative albumin and globulin are candidates for a prognostic indicator of GC, but the preoperative serum globulin in our study was not significantly correlated with survival. We assume that prognostic indicators based on the ratio of albumin to globulin are more accurate considering the following advantages. Firstly, AGR can take into account two identified predictors, which makes it more powerful than each alone. We observed that low preoperative AGR (<1.36) could still identify patients who had a poorer prognosis, even if their serum albumin levels were normal (≥35 g/L; OR=1.7; 95% CI, 1.2-2.6; p=0.008). Secondly, AGR is calculated in the form of two values, which can avoid the influences of hemodilution or hemoconcentration (14) . However, we cannot also evade the disadvantages of AGR. Obviously, AGR still cannot eliminate the interference of unwanted components of globulin in the analysis results. Furthermore, serum albumin has a relatively stable value because of its half-life of about 20 days, while components of serum globulin have various half-lives, ranging from hours to several days. The level of serum albumin and globulin measured at the same time may reflect different periods of status (24) . In addition, Alkan (16) recognized that AGR was not a predictor but a misleader because AGR can be affected by multiple factors. It is similar to our finding that the level of preoperative AGR can be significantly influenced by gender, age, preoperative hemoglobin, and tumor size. However, in our opinion, this is exactly why AGR can make a comprehensive assessment on both physical condition and tumor status for predicting prognosis. It is true that preoperative AGR perhaps is not the most precise prognostic indicator, but it is a simple and efficient prognosis predicting biomarker that is shown in an increasing number of studies.
More interestingly, AGR may also be a potential risk factor for cancer incidence more than a predictor for cancer survival. A study involving 26,974 healthy individuals has demonstrated that low AGR was a risk factor for nine malignancies and significantly correlated with the morbidity of liver and hematologic malignancies (25) . From a genetic perspective, AGR was reported the target phenotype of the TNFRSF13B and FADS1 genes, but neither of these was associated with tumors (26) . Exploring the genetic basis of AGR for predicting cancer incidence may be the direction for our future research.
Adjuvant chemotherapy can improve the outcomes of the patients with resectable GC, which has been demonstrated by accumulating evidence (27 The limitations of our study are the retrospective design, a small sample from a single center, and the lack of specific nonalbumin proinflammatory protein levels. In spite of these limitations, to the best of our knowledge, our study is the first to discuss the relationship between preoperative AGR and the prognosis of GC patients. Further improved analyses to examine the prognostic value of preoperative AGR in GC patients are needed.
In summary, preoperative AGR was significantly associated with the OS of GC patients and low preoperative AGR was an independent risk factor for GC patients. Furthermore, preoperative AGR might be a reflection of both physical condition and tumor status, since age, gender, preoperative hemoglobin, and tumor size all had a significant impact on the level of preoperative AGR in our study. These findings suggest that preoperative AGR is a simple but efficient prognosis predicting biomarker in patients with GC. Further clinical and fundamental studies are needed to validate our demonstration. Informed Consent: Written informed consent was obtained from patients who participated in this study.
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